PROVX
Price
$21.40
Change
-$0.12 (-0.56%)
Updated
Dec 17 closing price
RGABX
Price
$75.91
Change
-$0.37 (-0.49%)
Updated
Dec 17 closing price
Ad is loading...

PROVX vs RGABX

Header iconPROVX vs RGABX Comparison
Open Charts PROVX vs RGABXBanner chart's image
Provident Trust Strategy
Price$21.40
Change-$0.12 (-0.56%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R2
Price$75.91
Change-$0.37 (-0.49%)
VolumeN/A
CapitalizationN/A
PROVX vs RGABX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PROVX vs. RGABX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PROVX is a Buy and RGABX is a Buy.

FUNDAMENTALS
Fundamentals
RGABX has more cash in the bank: 315B vs. PROVX (215M). PROVX pays higher dividends than RGABX: PROVX (1.29) vs RGABX (0.00). PROVX was incepted earlier than RGABX: PROVX (38 years) vs RGABX (23 years). RGABX is a more actively managed with annual turnover of: 31.00 vs. PROVX (12.00). RGABX has a lower initial minimum investment than PROVX: RGABX (250) vs PROVX (1000). RGABX annual gain was more profitable for investors over the last year : 34.26 vs. PROVX (24.09). RGABX return over 5 years is better than : 48.46 vs. PROVX (31.17).
PROVXRGABXPROVX / RGABX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence38 years23 years-
Gain YTD22.77732.96569%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets215M315B0%
Annual Yield % from dividends1.290.00-
Returns for 1 year24.0934.2670%
Returns for 3 years-7.0715.12-47%
Returns for 5 years31.1748.4664%
Returns for 10 years99.1783.09119%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WIT3.700.02
+0.54%
Wipro Limited
KALU75.18-1.14
-1.49%
Kaiser Aluminum Corp
KNF104.85-1.66
-1.56%
Knife River Corp
SLN6.51-0.23
-3.41%
Silence Therapeutics Plc
CDIO0.85-0.27
-24.11%
Cardio Diagnostics Holdings